Los Angeles County records some of California's highest chronic Hepatitis C rates. While brand Harvoni offers a near-complete cure, its US list price exceeds $84,000 for a 12-week course — an impossible barrier for most uninsured patients.
Resof L contains the same Ledipasvir and Sofosbuvir combination, achieving SVR12 cure rates above 95% in Genotype 1 patients. A full course costs under $500 when sourced from a licensed Indian manufacturer, compared to tens of thousands of dollars for the brand.
|
FAQ: How do I know generic Resof L will actually cure my Hepatitis C? Resof L uses the identical mechanism as brand Harvoni — Sofosbuvir inhibits the NS5B polymerase enzyme the virus needs to replicate, while Ledipasvir blocks the NS5A protein. Multiple peer-reviewed studies on generic Sofosbuvir/Ledipasvir combinations from WHO-prequalified manufacturers have confirmed SVR12 rates statistically equivalent to the original branded drug. Many gastroenterologists in the US now actively discuss generic options with patients who can't afford brand pricing. |
